Cancer Research 09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 2786-2793, May 1, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang-Wuu, S.
Right arrow Articles by Lampkin, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang-Wuu, S.
Right arrow Articles by Lampkin, B.

Chromosome Analysis of 31 Wilms' Tumors1

Sheng Wang-Wuu, Shirley Soukup2, Kevin Bove, Betsy Gotwals and Beatrice Lampkin

Departments of Human Genetics [S. W-W., S. S., B. G.], Pathology [K. B.], and Hematology/Oncology [B. L.], Children's Hospital Medical Center, Cincinnati, Ohio 45229

Cytogenetic analysis was done on 31 Wilms' tumors, including 2 renal tumors of clear cell sarcoma type, using short term cultures of primary tumors and/or nude mouse passages. Nonrandom secondary chromosome abnormalities, in particular, were noted as evidence of clonal evolution. Apparently normal karyotypes were found in 5 Wilms' tumors, all in patients ≤22 months old, and in one clear cell sarcoma. Abnormal karyotypes were seen in 25 tumors (80%); 6 were pseudodiploid, 3 were hypodiploid, and 16 (52%) were hyperdiploid, of which 8 had a modal number of 47–49 and 8 had a modal number of 50–55. Nonrandom structural abnormalities involved 1p/1q, 11p, 7p/7q, 16p/16q, 12q, and 17p/17q. Nonrandom numerical abnormalities included +6, +8, and +18. Trisomy 12 was the most common abnormality, structural or numerical, seen in 52% of tumors (81% of the hyperdiploid). In 2 tumors the +12 was the only apparent abnormality; in 1 other tumor an i(12q) was seen, suggesting that +12 may have special significance in the clonal progression of Wilms' tumor. Informative karyotypes of 68 Wilms' tumors from other reports were reviewed and compared to results in this series.

1 This work was supported by funds donated by Robert D. Lindner for Tumor Research and Phi Beta Psi Sorority. Investigators in Childrens Cancer Study Group contributed seven tumor samples. CCSG Grant 13539.

2 To whom requests for reprints should be addressed, at Children's Hospital Medical Center, Elland and Bethesda Avenues, Cincinnati, OH 45229.

Received 9/ 6/89. Revised 1/ 8/90.


This article has been cited by other articles:


Home page
J. Med. Genet.Home page
R H Scott, C A Stiller, L Walker, and N Rahman
Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour
J. Med. Genet., September 1, 2006; 43(9): 705 - 715.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
E. Yuan, C.-M. Li, D. J. Yamashiro, J. Kandel, H. Thaker, V. V. Murty, and B. Tycko
Genomic Profiling Maps Loss of Heterozygosity and Defines the Timing and Stage Dependence of Epigenetic and Genetic Events in Wilms' Tumors
Mol. Cancer Res., September 1, 2005; 3(9): 493 - 502.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.